ID   TD03
AC   CVCL_C0KS
SY   TD-03
DR   Wikidata; Q112930457
RX   PubMed=34287353;
WW   https://cbigr-open.loris.ca/c-big_ipsc_catalog_May2022.pdf
CC   From: Clinical Biospecimen Imaging and Genetic (C-BIG) Repository, Montreal Neurological Institute, McGill University; Montreal; Canada.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): PubMed=34287353
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 9,11
ST   D16S539: 9,11
ST   D21S11: 28,30
ST   D5S818: 9,11
ST   D7S820: 12
ST   TH01: 6,9
ST   TPOX: 8,9
ST   vWA: 14,15
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C0KR ! AJD002-3
SX   Male
AG   44Y
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 29-06-23; Version: 4
//
RX   PubMed=34287353; DOI=10.3390/mps4030050; PMCID=PMC8293472;
RA   Chen C.X.-Q., Abdian N., Maussion G., Thomas R.A., Demirova I., Cai E.,
RA   Tabatabaei M., Beitel L.K., Karamchandani J., Fon E.A., Durcan T.M.;
RT   "A multistep workflow to evaluate newly generated iPSCs and their
RT   ability to generate different cell types.";
RL   Methods Protoc. 4:50.1-50.21(2021).
//